BRAINSTORM CELL THERAPEUTICS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 14.25 million shares for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2017-08-14
- BRAINSTORM CELL THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2017-06-30 was 0.00 shares.
- BRAINSTORM CELL THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2017-03-31 was 14.25M shares.
- BRAINSTORM CELL THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2013-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2013-06-30 was 626.67K shares.
- BRAINSTORM CELL THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2012 was 981.67K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 60 month |
|---|---|---|---|---|---|---|
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 14.25M shares 10-Q · filed 2017-08-14 | ||||
| 2017-03-31 | 14.25M shares 10-Q · filed 2017-05-15 | |||||
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | 626.67K shares derived: sum of 2 quarters · filed 2013-11-14 | 4.63M shares 10-Q · filed 2013-11-14 | 4.63M shares derived: sum of 4 quarters · filed 2013-11-14 | ||
| 2013-06-30 | 626.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | 4.63M shares 10-Q · filed 2013-08-14 | 4.63M shares derived: sum of 3 quarters · filed 2013-08-14 | 5.44M shares derived: sum of 4 quarters · filed 2013-08-14 | ||
| 2013-03-31 | 4.00M shares 10-Q · filed 2013-05-09 | 4.00M shares derived: sum of 2 quarters · filed 2013-05-09 | 4.82M shares derived: sum of 3 quarters · filed 2013-05-09 | |||
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | 815.00K shares derived: sum of 2 quarters · filed 2013-03-14 | 981.67K shares 10-K · filed 2013-03-14 | |||
| 2012-09-30 | 815.00K shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | 981.67K shares 10-Q · filed 2012-11-13 | ||||
| 2012-06-30 | 166.67K shares 10-Q/A · filed 2012-08-29 | |||||
| 2012-04-30 | 166.67K shares 10-Q/A · filed 2012-08-29 | |||||
| 2009-12-31 | 53.33K shares 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |